Trade Advice Notice on fluxapyroxad and mefentrifluconazole in the product Revystar Fungicide

This consultation closed on 27 April 2021.
Consultation period: 
29 March 2021 to 27 April 2021

The APVMA invites comment on the proposed use of fluxapyroxad and mefentrifluconazole in the product Revystar Fungicide, for use on wheat, barley, oats and canola.

We invite written comment from 29 March 2021 to 27 April 2021 on the trade implications of this proposal.

The APVMA is able to consider comments relating to the legislative grounds for the assessment, which are the trade implications of the use of the product. The Trade Advice Notice provides a summary of the APVMA's residue and trade assessment.

Please note: submissions will be published on the APVMA’s website, unless you have asked for the submission to remain confidential, or if the APVMA chooses at its discretion not to publish any submissions received (refer to the public consultation coversheet).

Please lodge your submission using the public consultation coversheet, which provides options for how your submission will be published.

Note that all APVMA documents are subject to the access provisions of the Freedom of Information Act 1982 and may be required to be released under that Act should a request for access be made.

Please send your written submission and coversheet by email or post to:

Email: enquiries@apvma.gov.au

Post:
Executive Director, Risk Assessment Capability
Australian Pesticides and Veterinary Medicines Authority
GPO Box 3262
Sydney NSW 2001

Submissions received

The APVMA sought comments from interested stakeholders on the proposed use of fluxapyroxad and mefentrifluconazole in the product Revystar Fungicide, in a consultation that closed on 27 April 2021.

A total of 2 submissions were received from industry groups.

A copy of the published submissions is available on our website.

Consultation feedback

The APVMA is currently considering all submissions received as part of this consultation.

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.